Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

ACAN Oblitoxaximab injection [ PAC oblitoxaximab en injection]

Open
Doc5994436969International

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

NAICS

N/A

Place of Performance

CAN

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Due in 21 days

Get what you need to respond

No documents were posted with this contract.

  • Buyer contactEmail
  • Original solicitationLink to the source posting
Get the buyer contact

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseSources Sought
Posted

Sources Sought

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyGovernment of Canada / Gouvernement du Canada
Contacts1 person available
OfficeN/A

Full Description

Show more
Advanced Contract Award Notice(ACAN) - Oblitoxaximab Injection An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no supplier submits a statement of capabilities that meets the requirements set out in the ACAN, on or before the closing date stated in the ACAN, the contracting officer may then proceed with the award to the pre identified supplier. Purpose of this Advanced Contract Award Notice (ACAN): Public Services and Procurement Canada proposes to negotiate a contract with Elusys Therapeutics, Inc on behalf of Public Health Agency of Canada (PHAC). Requirement description: Public Health Agency of Canada (PHAC) has a requirement for Oblitoxaximab injection, an antitoxin used to treat inhalation anthrax. ************************************************************************ [ Préavis d’adjudication de contrat (PAC) – Oblitoxaximab en injection Un PAC est un avis public informant la collectivité des fournisseurs qu'un ministère ou organisme a l'intention d'attribuer un contrat pour des biens, des services ou des travaux de construction à un fournisseur sélectionné à l'avance, ce qui permet aux autres fournisseurs de signaler leur intérêt à soumissionner en présentant un énoncé des capacités. Si aucun fournisseur ne présente un énoncé des capacités qui satisfait aux exigences établies dans le PAC, au plus tard à la date de clôture indiquée dans le PAC, l'agent de négociation des contrats peut procéder à l'attribution du contrat au fournisseur sélectionné à l'avance. Raison du Préavis d’adjudication de contrat (PAC) Services Publics et Approvisionnement Canada propose de négocier un contrat avec Elusys Therapeutics Inc pour l’Agence de la santé publique du Canada (ASPC). Définition du besoin L’Agence de la santé publique du Canada (ASPC) a un besoin relatif à l’approvisionnement en oblitoxaximab en injection, une antitoxine utilisée pour traiter anthrax par inhalation.]

More opportunities from Government of Canada / Gouvernement du Canada

Same awarding agency

NAICS: 336412
New
International
Advanced Contract Award Notice - Safran Engine Repair and Overhaul [Préavis d’adjudication de contrat - Réparation et révision des moteurs de Safran]
Solicitation # M7594-271916
The Government of Canada, on behalf of the Royal Canadian Mounted Police (RCMP) Air Services Branch, has issued an Advance Contract Award Notice (ACAN) for the repair and overhaul of Safran Helicopter Engines, specifically the Arriel 2B, Arriel 2B1, Arriel 2E, and Arrius 2F models. The estimated total contract value is 16.8 million CAD, covering an initial three-year term and four irrevocable one-year option periods. The scope of work includes the supply and exchange of OEM-approved parts and the performance of Level 1 through 4 maintenance activities. All work must be performed at the contractor's facility and comply with Canadian Aviation Regulations (CARs) and Transport Canada standards, with all shipments accompanied by detailed certification documentation including total time and cycles since new and overhaul. The government intends to award the contract to a pre-identified supplier unless other suppliers submit a Statement of Capabilities by December 2, 2026, demonstrating they meet all mandatory requirements. Key requirements include being an Original Equipment Manufacturer (OEM) or an OEM-authorized facility, possessing specialized tooling, and maintaining sufficient lease engine capacity to support RCMP operations across Canada. Strict performance benchmarks are mandated, including responding to Aircraft on Ground (AOG) requests within 24 hours 95% of the time, delivering lease engines within 72 to 144 hours, and providing particle analysis reports within 48 hours. The contractor is responsible for all transportation costs between their facility and RCMP locations, and the RCMP reserves the right to conduct on-site or virtual compliance audits with two business days' notice.
Aircraft Engine and Engine Parts Manufacturing

POSTED

about 5 hours ago

DEADLINE

in 15 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS